drugset / Trial / NCT00234078
Dose-response Study of OPC-12759 Ophthalmic Suspension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the dose-response of OPC-12759 ophthalmic suspension in dry eye patients.
Timeline
- Start
- 2005-01
- Primary completion
- 2006-04
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rebamipide | Small molecule | 0.5 % | — |
| Subject | Rebamipide | Small molecule | 1 % | — |
| Subject | Rebamipide | Small molecule | 2 % | — |